LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells

L C Sutherland1, M Lerman, G T Williams

  • 1The Henry Hood Research Program, Sigfried and Janet Weis Center for Research, Geisinger Clinic, Danville 17822-2616, USA.

Oncogene
|June 23, 2001
PubMed

Insights

The LUCA-15 gene suppresses programmed cell death (apoptosis) by up-regulating Bcl-2, acting as a selective inhibitor of cell death. This confirms the LUCA-15 locus

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • LUCA-15 is a candidate tumor suppressor gene located at the 3p21.3 lung cancer locus.
  • A splice variant of LUCA-15 was previously shown to promote apoptosis and inhibit T cell proliferation.
  • Antisense cDNA targeting this variant suppressed CD95-mediated apoptosis.

Purpose of the Study:

  • To investigate the role of LUCA-15 itself in regulating apoptosis.
  • To determine the mechanism by which LUCA-15 affects the CD95 signaling pathway.
  • To assess the selectivity of LUCA-15's apoptotic inhibitory function.

Main Methods:

  • Overexpression of LUCA-15 in human Jurkat T cells.
  • Analysis of CD95-mediated apoptosis.
  • Assessment of Bcl-2 protein levels.
  • Induction of apoptosis using staurosporine and etoposide.

Main Results:

  • LUCA-15 overexpression suppressed CD95-mediated apoptosis in Jurkat cells.
  • Apoptosis suppression occurred before the final execution stage of the CD95 pathway.
  • LUCA-15 overexpression led to increased Bcl-2 protein levels.
  • LUCA-15 inhibited staurosporine-induced apoptosis but not etoposide-induced apoptosis.

Conclusions:

  • LUCA-15 acts as a selective inhibitor of programmed cell death.
  • The LUCA-15 gene locus is important for controlling apoptosis.
  • Up-regulation of Bcl-2 is associated with LUCA-15's anti-apoptotic effect.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...